Print Page   |   Sign In   |   Register
Newsletters
Blog Home All Blogs
Search all posts for:   

 

View all (70) posts »
 

Black Swan Connection October 2018

Posted By Administration, Thursday, October 18, 2018

September 2018

                

 6,462     1,414       472       131        6


Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

 

Breaking News

 

10-17-18

AxurRx BioPharma started at outperform with $6 stock price target at Oppenheimer

10-16-18 Trickle Research Initiates Research of
AzurRx Biopharma, Inc. (AZRX) 
12-24 Month Price Target $10.25

AzurRX made an announcement this morning regarding FDA Acceptance of IND application for Phase 2 Clinical Trial of MS1819-SD in Cystic Fibrosis patients. That announcement is included below. This announcement is (another) one of the major milestones we referenced in the initial coverage as a potential catalyst to much higher valuations of the company. As with their recent announcement regarding  positive results from their Phase IIa Exocrine Pancreatic Insufficiency trial in Chronic Pancreatitis, this is in our view, very positive news. Moreover, these two releases

in conjunction with one another may provide some additional insights.

Read Complete Research Update
 

10-10-18 Ascendiant Capital markets, LLC
Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
Buy Rating and Price Target $7.00
Click Here for Research Report

 

10-9-18 Social Reality, Inc. (SRAX)
SRAX Launches BIGtoken, the Platform for Consumers to Own, Verify and Sell Their Data

Claim your data by downloading the BIGtoken mobile app, available in the Apple App Store and Google Play; up to 10,000 initial Beta testers will take part in breaking down the barriers dividing consumers from the data they produce.

During the Beta phase, the top three most active users will be rewarded with Bitcoin for their participation. To join the Beta phase, consumers, first, sign up at: http://bigtoken.com/beta. Shortly thereafter, consumers will receive an "invite code" to activate the BIGtoken app, which is, now, available for download in the Apple App Store or Google Play:

Read Complete Release

 

09-28-18 Trickle Research Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
12-24 Month Price Target $9.25

*Please note WISA has been added to the Trickle Model portfolio with a 4 allocation weighting

Company Overview

Summit Wireless Technologies, Inc.(“Summit”) is a San Jose, California based high-fidelity wireless audio technology company.

We were introduced to Summit about 18 months ago, which included a demonstration of their wireless audio technology. Since that time, the Company has made considerable progress on several fronts, which we will attempt to delineate throughout this report. Further, our interest in the Company was recently enhanced when in late July (2018) in conjunction with a $12 million equity financing, the Company filed an S-1 registration statement and entered the public markets.

In short, the Company’s technology allows users to experience multichannel wireless high-fidelity audio across a variety of mediums (television, mobile and gaming for example) in an easy-to-setup, and increasingly affordable platform. The Company believes its technology provides multiple advantages over current wireless standards such as Bluetooth® and WiFi for certain applications that those legacy platforms currently address but are perhaps not well suited for.

When we first heard the Summit story, the company was a co-owner of WiSA LLC, which in turn operates the WiSA  Association. WiSA is an acronym for “Wireless Speaker and Audio”, and its purpose is to develop and maintain standards around Summit’s associated wireless intellectual property and in turn promote interoperability across the devices and brands of those utilizing the technology. Since our introduction to the Company, Summit has managed to acquire 100% of WiSA. As we will delineate further in this report, while we believe the Company’s ability to monetize its IP will be the primary driver of its valuation, we also think their ownership of the WiSA Association will represent an additional valuation leg that could become quite valuable on its own if the technology is able to establish adoption

in the wireless “immersive sound” industry.

Click Here for Research Report

 

10-3-18, Endurance Exploration Group, Inc. (“EXPL”)

operating through its previously announced joint venture, Swordfish Partners (the “Joint Venture”), is pleased to announce that it has acquired title to over 600 items and artifacts salvaged from the Steamship Pulaski.

Click Here for PR

 

10-1-18, Endurance Exploration Group, Inc. (“EXPL”) through a newly formed entity (or, “Affiliate”), has entered into a joint-venture with Global Marine Archaeological Research, LLC.  (“GMAR”)

Click Here

 

Trickle Research Issues Research Note 9-24-18 
AzurRx Biopharma, Inc.
12-24 Month Price Target $10.25

AzurRX made the following announcement this morning regarding positive results from their PhaseIIa clinical trial for MS1819-SD a treatment for chronic pancreatitis.

This announcement is one the major milestones we referenced in the initial coverage as a potential catalyst to much higher valuations of the

company. This is very positive news. To put this into perspective, as of this writing, the stock is trading up on the news, but currently the market cap of the stock is about $62 million. Recall, in the original research, we noted a company called Anthera Pharmaceuticals, Inc. (symbol: ANTH) that was developing a similar treatment and at times traded with a market cap in excess of $3 billion. Those trials subsequently failed. In short, again in line with our initial coverage, we think this clinical trial success substantially raises the awareness

(and by extension the chances) of AZRX relative to potential deals and/or transactions will large pharma players. As the Company notes, this is a billion market that is currently being addressed by a treatment that is decades old and not viewed particularly favorably by the FDA because it is an animal-based solution that carries associated risks.

Again, we think this may be a watershed event for AZRX and we reiterate our target of $10.25, which frankly, may prove to be a bargain.

Click Here for Research Note

 

Feature Article

The Big (Tesla) Short

By: Dave Lavigne

October 2018

Elon Musk has been in the news lately railing on the short sellers in his stock. Those diatribes have included criticisms of the SEC’s handling of the same (which in this regard he sometimes refers to as the “Shortseller Enrichment Commission”).  If we go a back a couple months, recall that Musk got himself in some trouble by tweeting some information regarding taking the company private.  Recognize, Mr. Musk’s short seller tirades are an extension of that go private mantra.  To edify, Mr. Musk is not the first CEO to consider the notion of going private to “punish” and essentially never have to worry about short sellers. The notion is, by going private, short sellers would be forced to “close” and reconcile their outstanding short positions.  Again, the threat of going private is just one potential remedy that several public CEO’s have considered to compromise the impact of short sellers, so Elon’s Musk’s mention of the same is not particularly surprising or even rare.

Not surprisingly, Musk’s assault on short sellers and the SEC’s defense of them, has been met with dissent from some of Wall Street’s finest.   Warren Buffet weighed in recently saying We have no objection to anybody selling Berkshire short at all," he said. "The more shorts, the better, because they have to buy the stock later on."  Further he noted; "There's nothing evil, per se, about — in my view — about selling things short," Buffett said. "Short sellers — the situations in which there have been huge short interests very often — very often have been later revealed to be frauds or semi-frauds," he added.

Read More

 

Great Article on the TESLA short situation which has been one of my (Not Dave Lavigne’s or Trickle Research’s) recommendations from time to time.

Tesla $268  – 10-16-18

SMM Original Recommendation

SELL Tesla, Inc. –TSLA Sept-2017   $376.00 Oct-16  price $268.00

If you’re short I’d probably cover and take my profits. All the bad news is in the market already and unless they really fall on their face operationally there is probably not a lot of immediate downside from here.

 

STOCK RECOMMENDATIONS FROM SMM:

Special Situations -Recommended by C. Dilley (SMM)
 

SHORT- Elio Motors, Inc. –ELIO Nov-2016  $11.80  Oct 16-18 price $3.95 starting to slip slide away again. (nice chance to add to short if you can get a borrow on ELIO). Still begging for money. This is never going to happen.

SELL Tesla, Inc. –TSLA Sept-2017   $376.00 Oct-16  price $268.00 I am still negative but don’t see a lot of downside from here. Cover your short position.

 

 

October 16-18 MODEL PORTFOLIO FOR TRICKLE RESEARCH, LLC.

 

Initiation

 

Price

Initiation

Price @

 

Stock

Symbol

Date

Allocation

Target

Cost Px.

10/12/2018

 

New Jersey Mining

NJMC

Multiple

5

$0.30

$0.12

$0.17

 

SRAX (Social Reality)

SRAX

Multiple

5

$7.50

$1.79

$4.54

 

Pure Cycle

PCYO

5/5/17

3

$12.00

$7.60

$11.475

 

Command Center

CCNI

9/8/17

4

$9.60

$4.44

$5.60

 

Endurance Exploration

EXPL

11/6/17

3

$0.29

$0.18

$0.19

 

Assure Holdings Corp.

ARHH

11/10/17

1

$5.75

$2.90

$1.86

 

Semler Scientific

SMLR

12/27/17

3

$15.50

$8.00

$30.02

 

AzurRx BioPharma

AZRZ

2/7/18

5

$10.25

$2.96

$2.59

 

Camino Minerals, Corp

CAMZF

4/6/18

4

$0.90

$0.26

$0.087

 

PetroShare Corp

PRHR

5/31/18

4

$3.20

$1.44

$1.35

 

Gold Resource Corp

GORO

7/30/18

4

$8.85

$6.49

$5.04

 

Summit Wirelss

WISA

9/28/18

4

$7.00

$4.30

$4.55

 

 

 

Initiation

 Termination 

 

Price

Initiation

Termination

Terminated Coverage

Symbol

Date

Date

Allocation

Target

Price

  Price

ID Watchdog

IDW

10/13/16

8/28/2017

4

$0.42

$0.14

$0.40  

GrowGeneration

GRWG

6/20/17

12/21/17

4

$3.40

$2.00

$3.44

Barfresh Food Group

BRFH

 

8/20/18

1

 

$0.55

$0.53

 

For complete details and assumptions please see the assumptions and explanations document Click Here

For a review and details on 2017 performance and model portfolio assumptions  Click Here

*Please note Dave Lavigne in the principal in Trickle Research and is also the editor of the Black Swan Connection Newsletter and an ongoing contributor to SMM.

 

 

 

 

Published by:
Stock Market Manager
www.smm.global
All rights reserved

Editor:
David Lavigne
dave@t4partners.com
720-394-1019                 

CEO:
Carl Dilley
Cdilley@smm.global
727-823-3987 

SMM Distribution Update

Distribution (Reach)

            SMM Global Twitter Acct     (Impressions last 30 days)      1,414

             SMM Global Facebook Page  (Reach last-30 days)              6,462
             
              SMM Linkedin Page                (contacts)                              472

             SMM Youtube Channel            (followers)                                6

             SMM Instagram                      (followers)                                    131      

              Direct Email                                                                 345,000

             Total                                                                             353,485

 

COMPANY QUOTES, LISTINGS RESEARCH AND NEWS

Company

 

 

 

Premium

Research

News

(listing, quotes, news, research)

 

 

 

Profile

Updates

Updates

Aethlon Medical, Inc. (AEMD)

 

Profile

 

 

Assure Holdings, Inc. (ARHH)

 

 

5-29-18

News

Antibe Therapeutics, Inc (ATBPF)

 

 

 

News

AzuerRx Biopharma, Inc. (AZRX)

 

10-16-18

News

Camino Minerals Corp. (CAMZF)

 

4-6-18

News

Canbiola, Inc. (CANB)

 

 

 

News

Chineseinvestors.com, Inc. (CIIX)

Profile

 

News

Command Center , Inc. (CCNI)

 

 

8-15-18

News

Endurance Exploration Group, Ltd (EXPL)

 

 Profile

1-25-18

News

Ecom Products Group (EPGC)

 

 

 

News

FULLSHARE HOLDINGS LTD. (607) HK

 

9-7-18

News

Galaxy Gaming, Inc. (GLXZ)

 

     Profile

 

 

Guangdong Land Holdings Limited (124) HK

9-3-18

News

Magnegas, Inc. (MNGA)

 

 

 

News

MOBI724 Global Solutions, Inc. (MOBIF)

 

 

News

New Jersey Mining Company (NJMC)

 

5-17-18

News

Petroshare Corp. (PRHR)

 

 

8-23-18

News

Summit Wireless Technologies, Inc.

 

 

10-2-18

News

Social Reality, Inc. (SRAX)

 

 

8-16-18

News

Zynex, Inc. (ZYXI)

 

 

8-9-18

News

 

 

Go to ValuEngine.com

 

 

Oct 15, 2018 by Steve Hach

For today's bulletin, we take a look at the demise of Sears Holdings (SHLD).

--Going, Going, GONE

American Icon Sears Run Into Ground

Sears Holdings Corporation (SHLD), the parent of Kmart and Sears, Roebuck and Co., is the leading home appliance retailer in North America and is a retail sales leader in tools, lawn and garden, home electronics, and automotive repair and maintenance. Key proprietary brands include Kenmore, Craftsman and DieHard, and a broad apparel offering, including such well-known labels as Lands' End, Jaclyn Smith and Joe Boxer, as well as the Apostrophe and Covington brands.

Click Here for Full Report

 

VALUATION WATCH: Overvalued stocks now make up 40.24% of our stocks assigned a

valuation and 14.9% of those equities are calculated to be overvalued by 20% or more.

Nine sectors are calculated to be overvalued.

 

 

SMM Research Subscription Service
Black Swan Research

Subscribers will get Real Time notification as Research Reports and updates are available as well as latest press releases and news on the companies covered.

Black Swan Research coverage is a compilation of some of the best independent providers of Micro Cap Research.  The service focuses on micro-cap companies that are typically not followed by Wall Street analysts.  In addition our subscription research service includes ValuEngine research on over 5,000 stocks with stock valuations, Buy/Hold/Sell recommendations, and forecasted target prices.

 Click Here for Complete Description

See Below for current coverage and info regarding our Research providers

Trickle Research Click Here for More info>>

*Research on the following companies is available to BS Research or Trickle research subscribers only

  • Pure Cycle (PCYO)  -
  • Semler Scientific, Inc. (SMLR)

Greenridge Global, LLC Click Here for More Info>>

Consilium Global Research Click Here for More Info>>

Falcon Strategic Research Click Here for More Info>>

Catalyst Research Management Group Click Here for more Info>>

ValuEngine Click Here for More Info >>

ValuEngine.com (VE) is a stock valuation and forecasting service founded by Ivy League finance academics. VE utilizes the most advanced quantitative techniques and analysis available.

To Subscribe Please click Here
 

Reg A or D 506(c)

If you have a Reg A or 506(c) offering you would like us to distribute to our database, please give us a ring or email to:
727-823-3987
cdilley@smm.global

 


Event Calendar Updates

Trickle Research and GVC Capital
Rocky Mountain Microcap Conference October 9, 2018.
BlackHawk, Colorado at Ameristar Resort

There was a great turnout and really well done presentations. Following are the links to presenting companies and look forward to research updates from Trickle Research

VolitionRX

OncoSec Medical Incorporated

AzurRx Biopharma, Inc.

Summit Wireless Technologies, Inc.

Zoned Properties, Inc.

Sierra Monitor Corporation

Biomerica, Inc.

New Jersey Mining Company

CBD Global Sciences

Where Food Comes From

AlvoPerto Energy, Ltd.
Social Reality, Inc.

If you’d like more information about any of the presenting companies please send us an email and we’ll put you in touch 

Dawson James Securities 
Small Cap Growth Conference Oct 29-30
Wyndham Grand Hotel –Jupiter Florida

Full Day--Two Track Presentations from over 30 Companies in Healthcare/Technology & Consumer Sectors

Uplist “Bootcamp” for Invited Guests

Monday Evening Panel/Welcome Cocktails

Last Year’s event was attended by over 250 of our Institutional, Family Office and High Net Worth Clients

Click Here to Register
 

NIBA New York Conference Oct 31- Nov-1

We’ll be attending, as long standing members, and ready to assist and make introductions.
If anyone would like to set up a meeting to discuss our services or any related matters, please email me at cdilley@smm.global.

The National Investment Banking Association (NIBA) is proud to host its 145th investment conference on Oct 31- Nov-1, 2018 at the Crown Plaza at Times Square in New York City.  


If you would like to make a corporate presentation Click Here to download the Presenting Company Application

To register as an attendee click the link below

 

This post has not been tagged.

Share |
Permalink | Comments (0)
 
Community Search
Sign In